Design and chemical mechanism of action of therapeutic metal complexes, including catalytic organometallic anticancer complexes, photoactivated metal anticancer complexes, metallomacrocycles as antivirals and stem-cell-mobilising agents, metalloantibiotics, dynamic metallomics, and single-metal-atom and metal-nanoparticle coordination chemistry.
Groups at Warwick
- Fellow of the Royal Society.
Peter Sadler obtained his BA, MA and DPhil at the University of Oxford. Subsequently he was a Medical Research Council Research Fellow at the University of Cambridge and National Institute of Medical Research. From 1973-96 he was Lecturer, Reader and Professor at Birkbeck College, University of London, and from 1996-2007 Crum Brown Chair of Chemistry at the University of Edinburgh, also Director of the Edinburgh Protein Interaction Centre and EastChem Cancer Research UK Cancer Medicinal Chemistry Centre. In June 2007 he took up a Chair in Chemistry at the University of Warwick as Head of Department, where he is now a Professor.
Peter is a Fellow of the Royal Society of Chemistry (FRSC), the Royal Society of Edinburgh (FRSE), and the Royal Society of London (FRS), and an EPSRC RISE Fellow (Recognising Inspirational Scientists and Engineers). He is also an Honorary Fellow of the Chemical Research Society of India, an Honorary Fellow of the Chinese Chemical Society, and a Fellow of the European Academy of Sciences.
He was awarded the Royal Society Davy Medal in 2022, for pioneering the research field of medicinal inorganic chemistry, "Metals in Medicine", and the design of new metallodrugs with novel mechanisms of action. His team were awarded a 2022 Royal Society of Chemistry Dalton Division Horizon Prize.